These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8373918)

  • 21. Inter-relationships of intermediate phenotypes for serotonin function, impulsivity, and a 5-HT2A candidate allele: His452Tyr.
    Reist C; Mazzanti C; Vu R; Fujimoto K; Goldman D
    Mol Psychiatry; 2004 Sep; 9(9):871-8. PubMed ID: 15037867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences between morning and afternoon hormonal responses to D-fenfluramine in healthy humans.
    Monteleone P; Bortolotti F; Orazzo C; Serino I; Maj M
    Psychoneuroendocrinology; 1997 Feb; 22(2):79-87. PubMed ID: 9149330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seasonal variation in plasma prolactin response to D-fenfluramine in healthy subjects.
    Monteleone P; La Rocca A; Fuschino A; Bortolotti F; Maj M
    Psychoneuroendocrinology; 1999 Feb; 24(2):201-8. PubMed ID: 10101728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of effect of hydrocortisone treatment on d-fenfluramine-mediated prolactin release.
    Young AH; Rue J; Odontiadis J; Cowen PJ
    Psychopharmacology (Berl); 1998 Mar; 136(2):198-200. PubMed ID: 9551777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma prolactin response to D-fenfluramine is blunted in bulimic patients with frequent binge episodes.
    Monteleone P; Brambilla F; Bortolotti F; Ferraro C; Maj M
    Psychol Med; 1998 Jul; 28(4):975-83. PubMed ID: 9723152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of midbrain raphe lesion or 5,7-dihydroxytryptamine treatment on the prolactin-releasing action of quipazine and D-fenfluramine in rats.
    Quattrone A; Schettini G; di Renzo G; Tedeschi G; Preziosi P
    Brain Res; 1979 Sep; 174(1):71-9. PubMed ID: 487124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma oxytocin in response to pharmaco-challenge to D-fenfluramine and placebo in healthy men.
    Lee R; Garcia F; van de Kar LD; Hauger RD; Coccaro EF
    Psychiatry Res; 2003 May; 118(2):129-36. PubMed ID: 12798977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of clomipramine and lithium on fenfluramine-induced hormone release in major depression.
    Shapira B; Yagmur MJ; Gropp C; Newman M; Lerer B
    Biol Psychiatry; 1992 May; 31(10):975-83. PubMed ID: 1511080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological characterization of serotonin receptors involved in the control of prolactin secretion.
    Di Renzo G; Amoroso S; Taglialatela M; Canzoniero L; Basile V; Fatatis A; Annunziato L
    Eur J Pharmacol; 1989 Mar; 162(2):371-3. PubMed ID: 2524399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma prolactin, adrenocorticotrophic hormone and cortisol after administration of d-fenfluramine or placebo to healthy subjects.
    Gorard DA; Taylor TM; Medbak SH; Perry LA; Libby GW; Farthing MJ
    Int Clin Psychopharmacol; 1993; 8(2):123-8. PubMed ID: 8393895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects.
    Cleare AJ; Murray RM; O'Keane V
    Neuropsychopharmacology; 1996 May; 14(5):349-54. PubMed ID: 8703303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does metergoline selectively attenuate 5-HT mediated prolactin release?
    Ellis PM; Gartside SE; Ware CJ; Campling GM; Cowen PJ
    Psychopharmacology (Berl); 1991; 105(1):129-31. PubMed ID: 1745704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolactin response to d-fenfluramine in postmenopausal women on and off ERT: comparison with young women.
    van Amelsvoort TA; Abel KM; Robertson DM; Daly E; Critchley H; Whitehead M; Murphy DG
    Psychoneuroendocrinology; 2001 Jul; 26(5):493-502. PubMed ID: 11337133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lithium treatment and serotoninergic function. Neuroendocrine and behavioral responses to intravenous tryptophan in affective disorder.
    Price LH; Charney DS; Delgado PL; Heninger GR
    Arch Gen Psychiatry; 1989 Jan; 46(1):13-9. PubMed ID: 2910219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain serotonin (5-HT) neuroendocrine function in patients taking cholesterol-lowering drugs.
    Delva NJ; Matthews DR; Cowen PJ
    Biol Psychiatry; 1996 Jan; 39(2):100-6. PubMed ID: 8717607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of prolactin response to d-fenfluramine to behavioral and questionnaire assessments of aggression in personality-disordered men.
    Coccaro EF; Berman ME; Kavoussi RJ; Hauger RL
    Biol Psychiatry; 1996 Aug; 40(3):157-64. PubMed ID: 8830948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered prolactin response to M-chlorophenylpiperazine in monkeys previously treated with 3,4-methylenedioxymethamphetamine (MDMA) or fenfluramine.
    Hatzidimitriou G; Tsai EH; McCann UD; Ricaurte GA
    Synapse; 2002 Apr; 44(1):51-7. PubMed ID: 11842446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lithium increases 5-HT-mediated prolactin release.
    McCance SL; Cohen PR; Cowen PJ
    Psychopharmacology (Berl); 1989; 99(2):276-81. PubMed ID: 2508166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function.
    O'Keane V; Dinan TG
    Am J Psychiatry; 1991 Aug; 148(8):1009-15. PubMed ID: 1853948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolactin response to D-fenfluramine challenge test as a predictor of treatment response to haloperidol in acute schizophrenia.
    Mohr P; Horácek J; Motlová L; Libiger J; Czobor P
    Schizophr Res; 1998 Feb; 30(1):91-9. PubMed ID: 9542792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.